Study design
This was a non-inferiority, multi-centered, randomized, double-blinded, controlled trial. This study was approved by the Institutional Board Review of the Royal Thai Army Medical Department and Khon Kaen University (Approval number IRBRTA 700/2562 and HE621569) and was retrospectively registered at Thai clinical trials registry (TCTR20210224002) and approved on 24/02/2021. The study was conducted in accordance with the Declaration of Helsinki and followed the International Conference for Harmonization Guidelines for Good Clinical Practice. Written informed consent was obtained from each patient before study participation.